(risperidone) extended-release injectable suspension
The information contained in this learning resource contains a portion of the product information. For full details see the product information by each product owner. A full list can be found in the References tab.
Neither a loading dose nor supplemental oral risperidone are recommended when switching to UZEDY
Neither a loading dose nor supplemental oral risperidone are recommended when switching to UZEDY
Initial UZEDY dose is based on prior daily PO risperidone dose:
No10
White to off-white, opaque, viscous suspension10
UZEDY is viscous and forceful downward flicks are required to move the bubble to the cap of the syringe. Failure to move the bubble to the cap of the syringe could result in incomplete dosing.
Firmly hold the syringe by the white collar.
Flick syringe forcefully 3 times to move the bubble to the cap. Flick with a forceful downward whipping motion of your full arm to move the bubble to the cap of the syringe, and repeat this action 3 times to ensure the bubble is at the cap of the syringe. Standing while you do this may help achieve required force.
Check that the bubble is at the cap of the syringe. The bubble will appear partially opaque. Holding the syringe up to light or against a dark backdrop may improve visibility. If the bubble is not at the cap, repeat the flicking motions until it is.10
Once the carton has been opened, administer to the patient or discard.10
710
Single-dose, prefilled syringe kit
Following both once monthly (50 mg to 125 mg) and once every 2 months dosing (100 mg to 250 mg), the mean exposure of risperidone and 9-hydroxyrisperidone combined of UZEDY corresponds to that of oral risperidone (2 mg to 5 mg/day) administered over an equivalent dosing period.10
0.14 mL (50 mg dose) - 0.70 mL (250 mg dose):10
5/810
2110
SC (abdominal; back or outer area of upper arm)10
n/a
n/a
21 gauge, 5/8-inch needle10
White to off-white, opaque, viscous suspension10
Single-dose, prefilled syringe kit
1 single-dose, prefilled, glass syringe
+
1 safety needle for drug administration10
Yes10
Store in refrigerator (36°F-46°F; 2°C-8°C).10
At room temperature (68°F-77°F; 20°C-25°C) for up to 90 days (in original, unopened packaging).
If unopened, UZEDY may be returned to refrigerated storage within 90 days. Once the carton is opened, administer UZEDY or discard.10
Yes (store in original carton to protect from light).10
Once the carton has been opened, administer to the patient or discard.10
Remove the kit from refrigerated storage and allow the package to sit at room temperature (68°F-77°F; 20°C-25°C) for at least 30 minutes.
UZEDY is solid at refrigerated temperatures and viscous at room temperature. It must reach room temperature prior to administration. Do not warm in any other way and keep protected from light.10
UZEDY is viscous and forceful downward flicks are required to move the bubble to the cap of the syringe. Failure to move the bubble to the cap of the syringe could result in incomplete dosing.
Firmly hold the syringe by the white collar.
Flick syringe forcefully 3 times to move the bubble to the cap. Flick with a forceful downward whipping motion of your full arm to move the bubble to the cap of the syringe, and repeat this action 3 times to ensure the bubble is at the cap of the syringe. Standing while you do this may help achieve required force.
Check that the bubble is at the cap of the syringe. The bubble will appear partially opaque. Holding the syringe up to light or against a dark backdrop may improve visibility. If the bubble is not at the cap, repeat the flicking motions until it is.10
Once the carton has been opened, administer to the patient or discard.10
By clicking the button below you agree to the following:
I am a US Health Care Professional.
I understand that S.C.O.P.E. is for educational purposes only and not to be used for the treatment or diagnosis of schizophrenia, nor is it a substitute for clinical judgment or guidelines.